Field of Invention
An improved transcatheter prosthetic heart valve includes structural members, such as in the form of wire frames, which provide support for the valve and aid in reducing or preventing leakage.
Background
Valvular heart disease and specifically aortic and mitral valve disease is a significant health issue in the US. Annually approximately 90,000 valve replacements are conducted in the US. Traditional valve replacement surgery, the orthotopic replacement of a heart valve, is an “open heart” surgical procedure. Briefly, the procedure necessitates a surgical opening of the thorax, initiation of extra-corporeal circulation with a heart-lung machine, stopping and opening the heart, excision and replacement of the diseased valve, and re-starting of the heart. While valve replacement surgery typically carries a 1-4% mortality risk in otherwise healthy persons, a significantly higher morbidity is associated to the procedure, largely due to the necessity for extra-corporeal circulation. Further, open heart surgery is often poorly tolerated in elderly patients.
Thus if the extra-corporeal component of the procedure could be eliminated, morbidities and cost of valve replacement therapies would be significantly reduced.
While replacement of the aortic valve in a transcatheter manner is the subject of intense investigation, lesser attention has been focused on the mitral valve. This is in part reflective of the greater level of complexity associated to the native mitral valve apparatus and thus a greater level of difficulty with regards to inserting and anchoring the replacement prosthesis.
Various problems exist in this field, including problems of insufficient articulation and sealing of the valve within the native annulus, pulmonary edema due to poor atrial drainage, perivalvular leaking around the installed prosthetic valve, lack of a good fit for the prosthetic valve within the native mitral annulus, atrial tissue erosion, excess wear on the valve structures, interference with the aorta at the posterior side of the mitral annulus, and lack of customization, to name a few. Accordingly, there is still a need for an improved prosthetic mitral valve.
Apparatus, systems, and methods include a self-expanding wire frames for a prosthetic cardiovascular valve. The prosthetic cardiovascular valve includes a cylindrical framework defining a lumen. The cylindrical framework includes multiple generally diamond-shaped members. Each diamond-shaped member defines multiple lateral vertices and multiple longitudinal vertices. Each diamond-shaped member is coupled to one or more other diamond-shaped members. Each coupling can be at or about each of the lateral vertices of the diamond-shaped member.
Inner assembly 12 includes a self-expanding frame 100, an outer cylindrical wrap 152 disposed about the inner wire frame (to acts as a cover to prevent valvular leakage) and a leaflet structure 136 (comprised of articulating leaflets 138 that define a valve function). The leaflet structure 136 may be sewn to the inner wireframe 100. The wireframe 100 also has (tether) attachment apertures 111 to which the tether 160 can be attached. Tether 160 is connected to tether anchor 154, which in this embodiment is implemented as an epicardial securing pad.
Outer assembly 14 includes an outer stent or frame 144, an outer cover 150, and a cuff covering 148. In this embodiment, outer frame 144 has a flared, articulating collar or cuff 146 over which the cuff covering 148 is disposed. Cuff 146 has a D-shaped section 162 to accommodate and solve left ventricular outflow tract (LVOT) obstruction issues.
Cuff 146 may be configured a substantially flat plate that projects beyond the diameter of the tubular body of outer frame 144 to form a rim or border. The terms flared end, cuff, flange, collar, bonnet, apron, or skirting used interchangeable herein. When the tubular body of frame 144 is pulled through the aperture of a mitral valve aperture, the mitral annulus, such as by tether loops, in the direction of the left ventricle, the cuff acts as a collar to stop the frame from traveling any further through the mitral valve aperture. The entire prosthetic valve is held by longitudinal forces between the cuff, which is seated in the left atrium and mitral annulus, and the ventricular tethers attached to the left ventricle.
Cuff 146 may be formed from a stiff, flexible shape-memory material such as the nickel-titanium alloy material Nitinol® formed as wire, and covered by cuff covering 148, which may be formed of stabilized tissue or other suitable biocompatible or synthetic material. In one embodiment, the cuff is constructed from independent articulating radial tines or posts of wire extending axially around the circumference of the bend or seam where cuff 146 transitions to the tubular body of frame 144 (in an integral flared end or cuff) or where cuff 146 is attached to the frame body (in an implementation in which they are separate, but joined components).
With cuff cover 148 in place articulating radial tines or posts of wire provide the cuff the ability to move up and down, to articulate, along the longitudinal axis that runs through the center of frame 144. In other words, the individual articulating radial tines or posts of wire can independently move up and down, and can spring back to their original position due to the relative stiffness of the wire. The tissue or material that covers the cuff wire has a certain modulus of elasticity such that, when attached to the wire of the cuff, is able to allow the wire spindles to move. This flexibility gives the cuff, upon being deployed within a patient's heart, the ability to conform to the anatomical shape necessary for a particular application. In the example of a prosthetic mitral valve, the cuff is able to conform to the irregularities of the left atrium and shape of the mitral annulus, and to provide a tight seal against the atrial tissue adjacent the mitral annulus and the tissue within the mitral annulus. As stated previously, this feature provides a degree of flexibility in sizing the mitral valve and prevents blood from leaking around the implanted prosthetic heart valve.
An additional aspect of the cuff dimension and shape is that, when fully seated and secured, the edge of the cuff preferably should not be oriented laterally into the atrial wall, in which orientation it might produce a penetrating or cutting action on the atrial wall.
In some embodiments, the wire spindles of the cuff are substantially uniform in shape and size. In some embodiments, each loop or spindle may be of varying shapes and sizes. In this example, it is contemplated that the articulating radial tines or posts of wire may form a pattern of alternating large and small articulating radial tines or posts of wire, depending on where the valve is being deployed. In the case of a prosthetic mitral valve, pre-operative imaging may allow for customizing the structure of the cuff depending on a particular patient's anatomical geometry in the vicinity of the mitral annulus.
The cuff is constructed so as to provide sufficient structural integrity to withstand the intracardiac forces without collapsing.
Inner frame 100 and outer frame or frame 144, including cuff 146, are preferably formed to be deformed (compressed and/or expanded) and, when released, return to their original (undeformed) shapes. To achieve this, the components are preferably formed of materials, such as metals or plastics, that have shape memory properties. With regards to metals, Nitinol® has been found to be especially useful since it can be processed to be austenitic, martensitic or super elastic. Martensitic and super elastic alloys can be processed to demonstrate the required compression features. Thus, inner frame 100 and outer frame or frame 144, including cuff 145, are preferably constructed of Nitinol®, and are capable of maintaining their functions while under longitudinal forces that might cause a structural deformation or valve displacement. Other shape memory alloys, such as Cu—Zn—Al—Ni alloys, and Cu—Al—Ni alloys, may be used.
Inner frame 100 and outer frame or frame 144, including cuff 146, are preferably formed from a laser cut, thin-walled tube of Nitinol® The laser cuts form regular cutouts in the thin Nitinol® tube. Secondarily the tube is placed on a mold of the desired shape, heated to the martensitic temperature and quenched. The treatment of the frame in this manner will form a flared end or cuff that has shape memory properties and will readily revert to the memory shape at the calibrated temperature.
Alternatively, these components may be constructed from braided wire
The cuff provides several functions. The first function is to inhibit perivalvular leakage and regurgitation of blood around the prosthesis. By flexing and sealing across the irregular contours of the annulus and atrium, leakage is minimized or prevented.
The second function of the cuff is to provide an adjustable and/or compliant bioprosthetic valve. The heart and its structures undergo complex conformational changes during the cardiac cycle. For example, the mitral valve annulus has a complex geometric shape known as a hyperbolic paraboloid that is shaped like a saddle, with the horn being anterior, the seat back being posterior, and the left and right valleys located medially and laterally. Beyond this complexity, the area of the mitral annulus changes over the course of the cardiac cycle. Further, the geometry of the tricuspid valve and tricuspid annulus continues to be a topic of research, posing its own particular problems. Accordingly, compliance is a very important but unfortunately often overlooked requirement of cardiac devices. Compliance here refers to the ability of the valve to change conformation with the native annulus in order to maintain structural position and integrity throughout the cardiac cycle. Compliance with the motion of the heart is a particularly useful feature, especially the ability to provide localized compliance where the underlying surfaces are acting differently from the adjacent surfaces. This ability to vary throughout the cardiac cycle allows the valve to remain seated and properly deployed in a manner not heretofore provided.
Additionally, compliance may be achieved through the use of the tethers where the tethers are preferably made from an elastic material. Tether-based compliance may be used alone, or in combination with the cuff-based compliance.
The third function of the cuff is to enable the valve, during implantation surgery, to conform to the irregular surfaces of the atrium. This function can be enhanced by the use of independent tethers, allowing for side-to-side fitting of the valve within the annulus. For example, where three tethers are used, they can be spaced circumferentially about 120 degrees relative to each other, which allows the surgeon to observe whether or where perivalvular leaking might be occurring and to pull on one side or the other to create localized pressure and reduce or eliminate the leakage.
The fourth function of the cuff is to counter the forces that act to displace the prosthesis toward/into the ventricle (i.e. atrial pressure and flow-generated shear stress) during ventricular filling.
The heart is known to generate an average left atrial pressure between about 8 and 30 mm Hg (about 0.15 to 0.6 psi). This left atrial filling pressure is the expected approximate pressure that would be exerted in the direction of the left ventricle when the prosthesis is open against the outer face of the flared end or cuff as an anchoring force holding the flared end or cuff against the atrial tissue that is adjacent the mitral valve. Cuff 146 counteracts this longitudinal pressure against the prosthesis in the direction of the left ventricle to keep the valve from being displaced or slipping into the ventricle. In contrast, left ventricular systolic pressure, normally about 120 mm Hg, exerts a force on the closed prosthesis in the direction of the left atrium. The tethers counteract this force and are used to maintain the valve position and withstand the ventricular force during ventricular contraction or systole. Accordingly, cuff 146 has sufficient structural integrity to provide the necessary tension against the tethers without being dislodged and pulled into the left ventricle. After a period of time, changes in the geometry of the heart and/or fibrous adhesion between prosthesis and surrounding cardiac tissues may assist or replace the function of the ventricular tethers in resisting longitudinal forces on the valve prosthesis during ventricular contraction.
Additional features of the cuff include that it functions to strengthen the leaflet assembly/frame complex by providing additional structure. Further, during deployment, the cuff functions to guide the entire structure, the prosthetic valve, into place at the mitral annulus during deployment and to keep the valve in place once it is deployed. Another important function is to reduce pulmonary edema by improving atrial drainage.
The valve leaflets are held by, or within, a leaflet assembly. In some embodiments, the leaflet assembly comprises a leaflet wire support structure to which the leaflets are attached and the entire leaflet assembly is housed within the frame body. In this embodiment, the assembly is constructed of wire and stabilized tissue to form a suitable platform for attaching the leaflets. In this aspect, the wire and stabilized tissue allow for the leaflet structure to be compressed when the prosthetic valve is compressed within the deployment catheter, and to spring open into the proper functional shape when the prosthetic valve is opened during deployment. In this embodiment, the leaflet assembly may optionally be attached to and housed within a separate cylindrical liner made of stabilized tissue or material, and the liner is then attached to line the interior of the frame body.
In this embodiment, the leaflet wire support structure is constructed to have a collapsible/expandable geometry. In some embodiments, the structure is a single piece of wire. The wireform is, in one embodiment, constructed from a shape memory alloy such as Nitinol®. The structure may optionally be made of a plurality of wires, including between 2 to 10 wires. Further, the geometry of the wire form is without limitation, and may optionally be a series of parabolic inverted collapsible arches to mimic the saddle-like shape of the native annulus when the leaflets are attached. Alternatively, it may optionally be constructed as collapsible concentric rings, or other similar geometric forms, each of which is able to collapse or compress, then expand back to its functional shape. In some embodiments, there may be 2, 3 or 4 arches. In another embodiment, closed circular or ellipsoid structure designs are contemplated. In another embodiment, the wire form may be an umbrella-type structure, or other similar unfold-and-lock-open designs. In some embodiments utilizes super elastic Nitinol® wire approximately 0.015″ in diameter. In this embodiment, the wire is wound around a shaping fixture in such a manner that 2-3 commissural posts are formed. The fixture containing the wrapped wire is placed in a muffle furnace at a pre-determined temperature to set the shape of the wire form and to impart its super elastic properties. Secondarily, the loose ends of the wireform are joined with a stainless steel or Nitinol® tube and crimped to form a continuous shape. In some embodiments, the commissural posts of the wireform are adjoined at their tips by a circular connecting ring, or halo, whose purpose is to minimize inward deflection of the post(s).
In some embodiments, the leaflet assembly is constructed solely of stabilized tissue or other suitable material without a separate wire support structure. The leaflet assembly in this embodiment is also disposed within the lumen of the frame and is attached to the frame to provide a sealed joint between the leaflet assembly and the inner wall of the frame. By definition, it is contemplated within the scope of the invention that any structure made from stabilized tissue and/or wire(s) related to supporting the leaflets within the frame constitute a leaflet assembly. In this embodiment, stabilized tissue or suitable material may also optionally be used as a liner for the inner wall of the frame and is considered part of the leaflet assembly.
Liner tissue or biocompatible material may be processed to have the same or different mechanical qualities, such as thickness, durability, etc., from the leaflet tissue.
Multiple types of tissue and biocompatible material may be used to cover the cuff, to form the valve leaflets, to form a wireless leaflet assembly, and/or to line both the inner and/or outer lateral walls of outer frame 144. As stated previously, the leaflet component may be constructed solely from stabilized tissue, without using wire, to create a leaflet assembly and valve leaflets. In this aspect, the tissue-only leaflet component may be attached to the frame with or without the use of the wire form. In some embodiments, there can be anywhere from 1, 2, 3 or 4 leaflets, or valve cusps.
The tissue may be used to cover the inside of the frame body, the outside of the frame body, and the top and/or bottom side of the cuff wire form, or any combination thereof.
In some embodiments, the tissue used herein is optionally a biological tissue and may be a chemically stabilized valve of an animal, such as a pig. In some embodiments, the biological tissue is used to make leaflets that are sewn or attached to a metal frame. This tissue is chemically stabilized pericardial tissue of an animal, such as a cow (bovine pericardium) or sheep (ovine pericardium) or pig (porcine pericardium) or horse (equine pericardium).
Preferably, the tissue is bovine pericardial tissue. Examples of suitable tissue include that used in the products Duraguard®, Peri-Guard®, and Vascu-Guard®, all products currently used in surgical procedures, and which are marketed as being harvested generally from cattle less than 30 months old.
In some embodiments, the valve leaflets may optionally be made from a synthetic material such as polyurethane or polytetrafluoroethylene. Where a thin, durable synthetic material is contemplated, e.g. for covering the flared end or cuff, synthetic polymer materials such expanded polytetrafluoroethylene or polyester may optionally be used. Other suitable materials may optionally include thermoplastic polycarbonate urethane, polyether urethane, segmented polyether urethane, silicone polyether urethane, silicone-polycarbonate urethane, and ultra-high molecular weight polyethylene. Additional biocompatible polymers may optionally include polyolefins, elastomers, polyethylene-glycols, polyethersulphones, polysulphones, polyvinylpyrrolidones, polyvinylchlorides, other fluoropolymers, silicone polyesters, siloxane polymers and/or oligomers, and/or polylactones, and block co-polymers using the same.
In another embodiment, the valve leaflets may optionally have a surface that has been treated with (or reacted with) an anti-coagulant, such as, without limitation, immobilized heparin. Such currently available heparinized polymers are known and available to a person of ordinary skill in the art.
Alternatively, the valve leaflets may optionally be made from pericardial tissue or small intestine submucosal tissue.
In another embodiment, the prosthetic valve is sized and configured for use in areas other than the mitral annulus, including, without limitation, the tricuspid valve between the right atrium and right ventricle. Alternative embodiments may optionally include variations to the flared end or cuff structure to accommodate deployment to the pulmonary valve between the right ventricle and pulmonary artery, and the aortic valve between the left ventricle and the aorta. In one embodiment, the prosthetic valve is optionally used as a venous backflow valve for the venous system, including without limitation the vena cava, femoral, subclavian, pulmonary, hepatic, renal and cardiac. In this aspect, the flared end or cuff feature is utilized to provide additional protection against leaking.
As shown in
In some embodiments, the tether(s) may optionally be attached to the cuff to provide additional control over position, adjustment, and compliance. In some embodiments, one or more tethers are optionally attached to the cuff, in addition to, or optionally, in place of, the tethers attached to the outer frame 144. By attaching to the cuff and/or the frame, an even higher degree of control over positioning, adjustment, and compliance is provided to the operator during deployment.
During deployment, the operator is able to adjust or customize the tethers to the correct length for a particular patient's anatomy. The tether(s) also allows the operator to tighten the cuff onto the tissue around the valvular annulus by pulling the tether(s), which creates a leak-free seal.
In some embodiments, the tether(s) is optionally anchored to other tissue location(s) depending on the particular application of valve 10. In the case of a mitral valve, or the tricuspid valve, one or more tethers are optionally anchored to one or both papillary muscles, septum, and/or ventricular wall.
In some embodiments, the ventricular end of outer frame 144, or of inner frame 100, comes to 2-5 points onto which anchoring sutures or tether are affixed. The tethers will traverse the ventricle and ultimately be anchored to the epicardial surface of the heart approximately at the level of the apex. The tethers when installed under slight tension will serve to hold the valve in place, i.e. inhibit perivalvular leakage during systole.
The tethers, in conjunction with the cuff, provide greater compliance for the valve. The tethers may be made from surgical-grade materials such as biocompatible polymer suture material. Non-limiting examples of such material include ultra high-molecular weight polyethylene (UHMWPE), 2-0 exPFTE (polytetrafluoroethylene) or 2-0 polypropylene. In one embodiment the tethers are inelastic. One or more of the tethers may optionally be elastic to provide an even further degree of compliance of the valve during the cardiac cycle. Upon being drawn to and through the apex of the heart, the tethers may be fastened by a suitable mechanism such as tying off to a pledget or similar adjustable button-type anchoring device to inhibit retraction of the tether back into the ventricle. It is also contemplated that the tethers might be bioresorbable/bioabsorbable and thereby provide temporary fixation until other types of fixation take hold such a biological fibrous adhesion between the tissues and prosthesis and/or radial compression from a reduction in the degree of heart chamber dilation.
Valve 10 may optionally be deployed with a combination of installation tethers and permanent tethers, attached to outer frame 144, and/or cuff 146, and/or inner frame 100, the installation tethers being removed after the valve is successfully deployed. It is also contemplated that combinations of inelastic and elastic tethers may optionally be used for deployment and to provide structural and positional compliance of the valve during the cardiac cycle.
Valve 10 may be deployed as a prosthetic mitral valve using catheter delivery techniques. The entire valve 10 is compressed within a narrow catheter and delivered to the annular region of the native valve, preferably the left atrium, with a pre-attached tether apparatus. There, the valve 10 is pushed out of the catheter where it springs open into its pre-formed functional shape without the need for manual expansion using an inner balloon catheter. When the valve 10 is pulled into place, the outer frame 144 is seated in the native mitral annulus, leaving the cuff 146 to engage the atrial floor and prevent pull-through (where the valve is pulled into the ventricle). The native leaflets are not cut-away as has been taught in prior prosthetic efforts, but are used to provide a tensioning and sealing function around the outer frame 144. The valve 10 is preferably deployed asymmetrically to address LVOT problems, unlike non-accommodating prosthetic valves that push against the A2 anterior segment of the mitral valve and close blood flow through the aorta, which anatomically sits immediately behind the A2 segment of the mitral annulus. Thus, D-shaped section 162 is preferably deployed immediately adjacent/contacting the A2 segment since the flattened D-shaped section 162 is structurally smaller and has a more vertical profile (closer to paralleling the longitudinal axis of the outer frame) and thereby exerts less pressure on the A2 segment. Once valve 10 is properly seated, tether 160 may be extended out through the apical region of the left ventricle and secured using an epicardial pad 154 or similar suture-locking attachment mechanism.
Valve 10 is, in one embodiment, apically delivered through the apex of the left ventricle of the heart using a catheter system. In one aspect of the apical delivery, the catheter system accesses the heart and pericardial space by intercostal delivery. In another delivery approach, the catheter system delivers valve 10 using either an antegrade or retrograde delivery approach using a flexible catheter system, and without requiring the rigid tube system commonly used. In another embodiment, the catheter system accesses the heart via a trans-septal approach.
In some embodiments, the frame body extends into the ventricle about to the edge of the open mitral valve leaflets (approximately 25% of the distance between the annulus and the ventricular apex). The open native leaflets lay against the outside frame wall and parallel to the long axis of the frame (i.e. the frame holds the native mitral valve open).
In some embodiments, the diameter should approximately match the diameter of the mitral annulus. Optionally, the valve may be positioned to sit in the mitral annulus at a slight angle directed away from the aortic valve such that it is not obstructing flow through the aortic valve. Optionally, the outflow portion (bottom) of the frame should not be too close to the lateral wall of the ventricle or papillary muscle as this position may interfere with flow through the prosthesis. As these options relate to the tricuspid, the position of the tricuspid valve may be very similar to that of the mitral valve.
In one embodiment, to control the potential tearing of tissue at the apical entry point of the delivery system, a circular, semi-circular, or multi-part pledget may be employed. The pledget may be constructed from a semi-rigid material such as PTFE felt. Prior to puncturing of the apex by the delivery system, the felt is firmly attached to the heart such that the apex is centrally located. Secondarily, the delivery system is introduced through the central area, or orifice as it may be, of the pledget. Positioned and attached in this manner, the pledget acts to control any potential tearing at the apex.
In another embodiment the valve can be seated within the valvular annulus through the use of tines or barbs. These may be used in conjunction with, or in place of one or more tethers. The tines or barbs are located to provide attachment to adjacent tissue. In some embodiments, the tines are optionally circumferentially located around the bend/transition area between frame body 144 and the cuff 146. Such tines are forced into the annular tissue by mechanical means such as using a balloon catheter. In one non-limiting embodiment, the tines may optionally be semi-circular hooks that upon expansion of the frame body, pierce, rotate into, and hold annular tissue securely.
One embodiment of an inner frame 100 is shown in side view in
Another embodiment of inner frame 100 is shown in side view in
Another embodiment of inner frame 100 is shown in an opened and flattened view in
Another embodiment of an inner frame, in this instance designated 200, is shown in
Another embodiment of an inner frame, in this instance designated 300, is shown in flattened view in
Another embodiment of an inner frame, in this instance designated 400, is shown in side view in
A flattened view of another four-diamond embodiment of inner frame 400 is shown in a flattened view in
Another embodiment of an inner frame, in this instance designated 500, is shown in flattened view in
Another embodiment of an inner frame, in this instance designated 600, is shown in flattened view in
Another embodiment of an inner frame, in this instance designated 700, is shown in side view in
Another embodiment of a prosthetic valve is shown in exploded view in
Inner assembly 12 includes inner frame 302, outer cylindrical wrap 152, and leaflet structure 136 (including articulating leaflets 138 that define a valve function). As in the embodiment in
Outer assembly 14 includes outer frame 144. Outer frame 144 may also have in various embodiments an outer frame cover of tissue or fabric (not pictured), or may be left without an outer cover to provide exposed wireframe to facilitate in-growth. Outer frame 144 has an articulating collar or cuff 147 is covered by cover 148 of tissue or fabric. Cuff 147 may also have in some embodiments a vertical A2 section to accommodate and solve left ventricular outflow tract (LVOT) obstruction issues.
In this embodiment, tether 160 is connected to valve 10′ by outer frame 144, in contrast to the embodiment in
An embodiment of an outer frame 144 having attachment members or struts 113 is shown in
In contrast to connecting portion 242, cuff portion 246 and body portion 245 are configured to be expanded radially. Strut portion 243 forms a longitudinal connection, and radial transition, between the expanded body portion and the compressed connecting portion 242.
Another embodiment of a prosthetic valve is shown in exploded view in
Inner assembly 312 includes inner frame 340, outer cylindrical wrap 352, and leaflet structure 336 (including articulating leaflets 338 that define a valve function). As in the embodiment in
Outer assembly 314 includes outer frame 370. Outer frame 370 may also have in various embodiments an outer frame cover of tissue or fabric (not pictured), or may be left without an outer cover to provide exposed wireframe to facilitate in-growth. Outer frame 370 may also have an articulating collar or cuff 347 covered by cover 348 of tissue or fabric.
In this embodiment, tether 360 is connected to valve 10″ by inner frame 340, similar to the embodiment in
Inner frame 340 is shown in more detail in
Connecting portion 344 includes longitudinal extensions of the struts, connected circumferentially by pairs of micro-V's. Similar to connecting portion 242 of outer frame 244 in
In contrast to connecting portion 344, apex portion 341 and body portion 342 are configured to be expanded radially. Strut portion 343 forms a longitudinal connection, and radial transition, between the expanded body portion and the compressed connecting portion 344.
Body portion 342 includes six longitudinal posts, such as post 342A. The posts can be used to attach leaflet structure 336 to inner frame 340, and/or can be used to attach inner assembly 312 to outer assembly 314, such as by connecting inner frame 340 to outer frame 370. In the illustrated embodiment, the posts include openings through which connecting members (such as suture filaments and/or wires) can be passed to couple the posts to other structures.
Inner frame 340 is shown in a fully deformed, i.e. to the final, deployed configuration, in side view and bottom view in
Outer frame 370 of valve 10″ is shown in more detail in
Coupling portion 371 includes multiple openings or apertures, such as 371A, by which outer frame 370 can be coupled to inner frame 340, as discussed in more detail below.
In this embodiment, cuff portion 373 includes an indicator 374. In this embodiment, indicator 374 is simply a broader portion of the wire frame element of cuff portion 373, i.e. Indicator 374 is more apparent on radiographic or other imaging modalities than the surrounding wire frame elements of cuff portion 373. In other embodiments, indicator 374 can be any distinguishable feature (e.g., protrusion, notch, etc.) and/or indicia (e.g., lines, markings, tic marks, etc.) that enhance the visibility of the part of cuff portion 373 on which it is formed, or to which it is attached. Indicator 374 can facilitate the implantation of the prosthetic valve by providing a reference point or landmark that the operator can use to orient and/or position the valve (or any portion of the valve) with respect to the native valve or other heart structure. For example, during implantation, an operator can identify (e.g., using echocardiography) the indicator 373 when the valve is situated in a patient's heart. The operator can therefore determine the location and/or orientation of the valve and make adjustments accordingly.
Outer frame 370 is shown in a fully deformed, i.e. to the final, deployed configuration, in side view and top view in
Outer frame 370 and inner frame 340 are shown coupled together in
While various embodiments have been described above, it should be understood that they have been presented by way of example only, and not limitation, and as such, various changes in form and/or detail may be made. Any portion of the apparatus and/or methods described herein may be combined in any suitable combination, unless explicitly expressed otherwise. Where methods and/or schematics described above indicate certain events occurring in certain order, the ordering of certain events and/or flow patterns may be modified. Additionally, certain events may be performed concurrently in parallel processes when possible, as well as performed sequentially.
This application is a continuation of U.S. patent application Ser. No. 14/950,656, filed Nov. 24, 2015, which is a continuation of International Application No. PCT/US2014/040188, filed May 30, 2014, which claims priority to and is a continuation-in-part of U.S. patent application Ser. No. 14/155,417, filed Jan. 15, 2014, which claims priority to and the benefit of U.S. Provisional Application No. 61/829,076, filed May 30, 2013. International Application No. PCT/US2014/040188 also claims priority to and the benefit of U.S. Provisional Application No. 61/829,076, filed May 30, 2013. Each of the foregoing disclosures is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
2697008 | Rowley | Dec 1954 | A |
3409013 | Berry | Nov 1968 | A |
3472230 | Fogarty et al. | Oct 1969 | A |
3476101 | Ross | Nov 1969 | A |
3548417 | Kisher | Dec 1970 | A |
3587115 | Shiley | Jun 1971 | A |
3657744 | Ersek | Apr 1972 | A |
3671979 | Moulopoulos | Jun 1972 | A |
3714671 | Edwards et al. | Feb 1973 | A |
3755823 | Hancock | Sep 1973 | A |
3976079 | Samuels et al. | Aug 1976 | A |
4003382 | Dyke | Jan 1977 | A |
4035849 | Angell et al. | Jul 1977 | A |
4056854 | Boretos et al. | Nov 1977 | A |
4073438 | Meyer | Feb 1978 | A |
4106129 | Carpentier et al. | Aug 1978 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4265694 | Boretos et al. | May 1981 | A |
4297749 | Davis et al. | Nov 1981 | A |
4339831 | Johnson | Jul 1982 | A |
4343048 | Ross et al. | Aug 1982 | A |
4345340 | Rosen | Aug 1982 | A |
4373216 | Klawitter | Feb 1983 | A |
4406022 | Roy | Sep 1983 | A |
4470157 | Love | Sep 1984 | A |
4490859 | Black et al. | Jan 1985 | A |
4535483 | Klawitter et al. | Aug 1985 | A |
4574803 | Storz | Mar 1986 | A |
4585705 | Broderick et al. | Apr 1986 | A |
4592340 | Boyles | Jun 1986 | A |
4605407 | Black et al. | Aug 1986 | A |
4612011 | Kautzky | Sep 1986 | A |
4626255 | Reichart et al. | Dec 1986 | A |
4638886 | Marietta | Jan 1987 | A |
4643732 | Pietsch et al. | Feb 1987 | A |
4655771 | Wallsten | Apr 1987 | A |
4692164 | Dzemeshkevich et al. | Sep 1987 | A |
4733665 | Palmaz | Mar 1988 | A |
4759758 | Gabbay | Jul 1988 | A |
4762128 | Rosenbluth | Aug 1988 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4787899 | Lazarus | Nov 1988 | A |
4787901 | Baykut | Nov 1988 | A |
4796629 | Grayzel | Jan 1989 | A |
4824180 | Levrai | Apr 1989 | A |
4829990 | Thuroff et al. | May 1989 | A |
4830117 | Capasso | May 1989 | A |
4851001 | Taheri | Jul 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4878906 | Lindemann et al. | Nov 1989 | A |
4883458 | Shiber | Nov 1989 | A |
4922905 | Strecker | May 1990 | A |
4923013 | De Gennaro | May 1990 | A |
4960424 | Grooters | Oct 1990 | A |
4966604 | Reiss | Oct 1990 | A |
4979939 | Shiber | Dec 1990 | A |
4986830 | Owens et al. | Jan 1991 | A |
4994077 | Dobben | Feb 1991 | A |
4996873 | Takeuchi | Mar 1991 | A |
5007896 | Shiber | Apr 1991 | A |
5026366 | Leckrone | Jun 1991 | A |
5032128 | Alonso | Jul 1991 | A |
5035706 | Giantureo et al. | Jul 1991 | A |
5037434 | Lane | Aug 1991 | A |
5047041 | Sammuels | Sep 1991 | A |
5059177 | Towne et al. | Oct 1991 | A |
5064435 | Porter | Nov 1991 | A |
5080668 | Bolz et al. | Jan 1992 | A |
5085635 | Cragg | Feb 1992 | A |
5089015 | Ross | Feb 1992 | A |
5152771 | Sabbaghian et al. | Oct 1992 | A |
5163953 | Vince | Nov 1992 | A |
5167628 | Boyles | Dec 1992 | A |
5192297 | Hull | Mar 1993 | A |
5201880 | Wright et al. | Apr 1993 | A |
5266073 | Wall | Nov 1993 | A |
5282847 | Trescony et al. | Feb 1994 | A |
5295958 | Shturman | Mar 1994 | A |
5306296 | Wright et al. | Apr 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5336616 | Livesey et al. | Aug 1994 | A |
5344442 | Deac | Sep 1994 | A |
5360444 | Kusuhara | Nov 1994 | A |
5364407 | Poll | Nov 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5397351 | Pavcnik et al. | Mar 1995 | A |
5411055 | Kane et al. | May 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5415667 | Frater | May 1995 | A |
5443446 | Shturman | Aug 1995 | A |
5480424 | Cox | Jan 1996 | A |
5500014 | Quijano et al. | Mar 1996 | A |
5545209 | Roberts et al. | Aug 1996 | A |
5545214 | Stevens | Aug 1996 | A |
5549665 | Vesely et al. | Aug 1996 | A |
5554184 | Machiraju | Sep 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5571175 | Vanney et al. | Nov 1996 | A |
5591185 | Kilmer et al. | Jan 1997 | A |
5607462 | Imran | Mar 1997 | A |
5607464 | Trescony et al. | Mar 1997 | A |
5609626 | Quijano et al. | Mar 1997 | A |
5639274 | Fischell et al. | Jun 1997 | A |
5662704 | Gross | Sep 1997 | A |
5665115 | Cragg | Sep 1997 | A |
5674279 | Wright et al. | Oct 1997 | A |
5697905 | Ambrosio | Dec 1997 | A |
5702368 | Stevens et al. | Dec 1997 | A |
5716417 | Girard et al. | Feb 1998 | A |
5728068 | Leone et al. | Mar 1998 | A |
5728151 | Garrison et al. | Mar 1998 | A |
5735842 | Krueger et al. | Apr 1998 | A |
5741333 | Frid | Apr 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5756476 | Epstein | May 1998 | A |
5769812 | Stevens et al. | Jun 1998 | A |
5792179 | Sideris | Aug 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5833673 | Ockuly et al. | Nov 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
5855597 | Jayaraman | Jan 1999 | A |
5855601 | Bessler | Jan 1999 | A |
5855602 | Angell | Jan 1999 | A |
5904697 | Gifford, III et al. | May 1999 | A |
5925063 | Khosravi | Jul 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5968052 | Sullivan et al. | Oct 1999 | A |
5968068 | Dehdashtian et al. | Oct 1999 | A |
5972030 | Garrison et al. | Oct 1999 | A |
5993481 | Marcade et al. | Nov 1999 | A |
6027525 | Suh et al. | Feb 2000 | A |
6042607 | Williamson, IV et al. | Mar 2000 | A |
6045497 | Schweich, Jr. et al. | Apr 2000 | A |
6063112 | Sgro et al. | May 2000 | A |
6077214 | Mortier et al. | Jun 2000 | A |
6099508 | Bousquet | Aug 2000 | A |
6132473 | Williams et al. | Oct 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6171335 | Wheatley et al. | Jan 2001 | B1 |
6174327 | Mertens et al. | Jan 2001 | B1 |
6183411 | Mortier et al. | Feb 2001 | B1 |
6210408 | Chandrasakaran et al. | Apr 2001 | B1 |
6217585 | Houser et al. | Apr 2001 | B1 |
6221091 | Khosravi | Apr 2001 | B1 |
6231602 | Carpentier et al. | May 2001 | B1 |
6245102 | Jayaraman | Jun 2001 | B1 |
6260552 | Mortier et al. | Jul 2001 | B1 |
6261222 | Schweich, Jr. et al. | Jul 2001 | B1 |
6264602 | Mortier et al. | Jul 2001 | B1 |
6287339 | Vazquez et al. | Sep 2001 | B1 |
6299637 | Shaolian | Oct 2001 | B1 |
6302906 | Goecoechea et al. | Oct 2001 | B1 |
6312465 | Griffin et al. | Nov 2001 | B1 |
6332893 | Mortier et al. | Dec 2001 | B1 |
6350277 | Kocur | Feb 2002 | B1 |
6358277 | Duran | Mar 2002 | B1 |
6379372 | Dehdashtian et al. | Apr 2002 | B1 |
6402679 | Mortier et al. | Jun 2002 | B1 |
6402680 | Mortier et al. | Jun 2002 | B2 |
6402781 | Langberg et al. | Jun 2002 | B1 |
6406420 | McCarthy et al. | Jun 2002 | B1 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6440164 | Di Matteo et al. | Aug 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6461382 | Cao | Oct 2002 | B1 |
6468660 | Ogle et al. | Oct 2002 | B2 |
6482228 | Norred | Nov 2002 | B1 |
6488704 | Connelly et al. | Dec 2002 | B1 |
6537198 | Vidlund et al. | Mar 2003 | B1 |
6540782 | Snyders | Apr 2003 | B1 |
6569196 | Vesely et al. | May 2003 | B1 |
6575252 | Reed | Jun 2003 | B2 |
6582462 | Andersen et al. | Jun 2003 | B1 |
6605112 | Moll | Aug 2003 | B1 |
6616684 | Vidlund et al. | Sep 2003 | B1 |
6622730 | Ekvall et al. | Sep 2003 | B2 |
6629534 | St. Goar et al. | Oct 2003 | B1 |
6629921 | Schweich, Jr. et al. | Oct 2003 | B1 |
6648077 | Hoffman | Nov 2003 | B2 |
6648921 | Anderson et al. | Nov 2003 | B2 |
6652578 | Bailey et al. | Nov 2003 | B2 |
6669724 | Park et al. | Dec 2003 | B2 |
6706065 | Langberg et al. | Mar 2004 | B2 |
6709456 | Langberg et al. | Mar 2004 | B2 |
6723038 | Schroeder et al. | Apr 2004 | B1 |
6726715 | Sutherland | Apr 2004 | B2 |
6730118 | Spenser et al. | May 2004 | B2 |
6733525 | Yang et al. | May 2004 | B2 |
6740105 | Yodfat et al. | May 2004 | B2 |
6746401 | Panescu | Jun 2004 | B2 |
6746471 | Mortier et al. | Jun 2004 | B2 |
6752813 | Goldfarb et al. | Jun 2004 | B2 |
6764510 | Vidlund et al. | Jul 2004 | B2 |
6797002 | Spence et al. | Sep 2004 | B2 |
6810882 | Langberg et al. | Nov 2004 | B2 |
6830584 | Seguin | Dec 2004 | B1 |
6854668 | Wancho et al. | Feb 2005 | B2 |
6855144 | Lesh | Feb 2005 | B2 |
6858001 | Aboul-Hosn | Feb 2005 | B1 |
6890353 | Cohn et al. | May 2005 | B2 |
6893460 | Spenser et al. | May 2005 | B2 |
6896690 | Lambrecht et al. | May 2005 | B1 |
6908424 | Mortier et al. | Jun 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
6936067 | Buchanan | Aug 2005 | B2 |
6945996 | Sedransk | Sep 2005 | B2 |
6955175 | Stevens et al. | Oct 2005 | B2 |
6974476 | McGuckin et al. | Dec 2005 | B2 |
6976543 | Fischer | Dec 2005 | B1 |
6997950 | Chawia | Feb 2006 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7018408 | Bailey et al. | Mar 2006 | B2 |
7044905 | Vidlund et al. | May 2006 | B2 |
7060021 | Wilk | Jun 2006 | B1 |
7077862 | Vidlund et al. | Jul 2006 | B2 |
7087064 | Hyde | Aug 2006 | B1 |
7100614 | Stevens et al. | Sep 2006 | B2 |
7101395 | Tremulis et al. | Sep 2006 | B2 |
7108717 | Freidberg | Sep 2006 | B2 |
7112219 | Vidlund et al. | Sep 2006 | B2 |
7115141 | Menz et al. | Oct 2006 | B2 |
7141064 | Scott et al. | Nov 2006 | B2 |
7175656 | Khairkhahan | Feb 2007 | B2 |
7198646 | Figulla et al. | Apr 2007 | B2 |
7201772 | Schwammenthal et al. | Apr 2007 | B2 |
7247134 | Vidlund et al. | Jul 2007 | B2 |
7252682 | Seguin | Aug 2007 | B2 |
7267686 | DiMatteo et al. | Sep 2007 | B2 |
7275604 | Wall | Oct 2007 | B1 |
7276078 | Spenser et al. | Oct 2007 | B2 |
7276084 | Yang et al. | Oct 2007 | B2 |
7316706 | Bloom et al. | Jan 2008 | B2 |
7318278 | Zhang et al. | Jan 2008 | B2 |
7326236 | Andreas et al. | Feb 2008 | B2 |
7329278 | Seguin et al. | Feb 2008 | B2 |
7331991 | Kheradvar et al. | Feb 2008 | B2 |
7335213 | Hyde et al. | Feb 2008 | B1 |
7374571 | Pease et al. | May 2008 | B2 |
7377941 | Rhee et al. | May 2008 | B2 |
7381210 | Zarbatany et al. | Jun 2008 | B2 |
7381218 | Schreck | Jun 2008 | B2 |
7393360 | Spenser et al. | Jul 2008 | B2 |
7404824 | Webler et al. | Jul 2008 | B1 |
7416554 | Lam et al. | Aug 2008 | B2 |
7422072 | Dade | Sep 2008 | B2 |
7429269 | Schwammenthal et al. | Sep 2008 | B2 |
7442204 | Schwammenthal et al. | Oct 2008 | B2 |
7445631 | Salahieh et al. | Nov 2008 | B2 |
7462191 | Spenser et al. | Dec 2008 | B2 |
7470285 | Nugent et al. | Dec 2008 | B2 |
7500989 | Solem et al. | Mar 2009 | B2 |
7503931 | Kowalsky et al. | Mar 2009 | B2 |
7510572 | Gabbay | Mar 2009 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7513908 | Lattouf | Apr 2009 | B2 |
7524330 | Berreklouw | Apr 2009 | B2 |
7527647 | Spence | May 2009 | B2 |
7534260 | Lattouf | May 2009 | B2 |
7556646 | Yang et al. | Jul 2009 | B2 |
7579381 | Dove | Aug 2009 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7591847 | Navia et al. | Sep 2009 | B2 |
7618446 | Andersen et al. | Nov 2009 | B2 |
7618447 | Case et al. | Nov 2009 | B2 |
7621948 | Herrmann et al. | Nov 2009 | B2 |
7632304 | Park | Dec 2009 | B2 |
7632308 | Loulmet | Dec 2009 | B2 |
7635386 | Gammie | Dec 2009 | B1 |
7674222 | Nikolic et al. | Mar 2010 | B2 |
7674286 | Alfieri et al. | Mar 2010 | B2 |
7695510 | Bloom et al. | Apr 2010 | B2 |
7708775 | Rowe et al. | May 2010 | B2 |
7748389 | Salahieh et al. | Jul 2010 | B2 |
7766961 | Patel et al. | Aug 2010 | B2 |
7789909 | Andersen et al. | Sep 2010 | B2 |
7803168 | Gifford et al. | Sep 2010 | B2 |
7803184 | McGuckin, Jr. et al. | Sep 2010 | B2 |
7803185 | Gabbay | Sep 2010 | B2 |
7806928 | Rowe et al. | Oct 2010 | B2 |
7837727 | Goetz et al. | Nov 2010 | B2 |
7854762 | Speziali et al. | Dec 2010 | B2 |
7892281 | Seguin et al. | Feb 2011 | B2 |
7896915 | Guyenot et al. | Mar 2011 | B2 |
7901454 | Kapadia et al. | Mar 2011 | B2 |
7927370 | Webler et al. | Apr 2011 | B2 |
7931630 | Nishtala et al. | Apr 2011 | B2 |
7942928 | Webler et al. | May 2011 | B2 |
7955247 | Levine et al. | Jun 2011 | B2 |
7955385 | Crittenden | Jun 2011 | B2 |
7972378 | Tabor et al. | Jul 2011 | B2 |
7988727 | Santamore et al. | Aug 2011 | B2 |
7993394 | Hariton et al. | Aug 2011 | B2 |
8007992 | Tian et al. | Aug 2011 | B2 |
8029556 | Rowe | Oct 2011 | B2 |
8043368 | Crabtree | Oct 2011 | B2 |
8052749 | Salahieh | Nov 2011 | B2 |
8052750 | Tuval et al. | Nov 2011 | B2 |
8052751 | Aklog et al. | Nov 2011 | B2 |
8062355 | Figulla et al. | Nov 2011 | B2 |
8062359 | Marquez et al. | Nov 2011 | B2 |
8070802 | Lamphere et al. | Dec 2011 | B2 |
8109996 | Stacchino et al. | Feb 2012 | B2 |
8142495 | Hasenkam et al. | Mar 2012 | B2 |
8152821 | Gambale et al. | Apr 2012 | B2 |
8157810 | Case et al. | Apr 2012 | B2 |
8167932 | Bourang et al. | May 2012 | B2 |
8167934 | Styrc et al. | May 2012 | B2 |
8187299 | Goldfarb et al. | May 2012 | B2 |
8206439 | Gomez Duran | Jun 2012 | B2 |
8216301 | Bonhoeffer et al. | Jul 2012 | B2 |
8226711 | Mortier et al. | Jul 2012 | B2 |
8236045 | Benichou et al. | Aug 2012 | B2 |
8241274 | Keogh et al. | Aug 2012 | B2 |
8252051 | Chau et al. | Aug 2012 | B2 |
8303653 | Bonhoeffer et al. | Nov 2012 | B2 |
8308796 | Lashinski et al. | Nov 2012 | B2 |
8323334 | Deem et al. | Dec 2012 | B2 |
8353955 | Styrc et al. | Jan 2013 | B2 |
RE44075 | Williamson et al. | Mar 2013 | E |
8449599 | Chau et al. | May 2013 | B2 |
8454656 | Tuval | Jun 2013 | B2 |
8470028 | Thornton et al. | Jun 2013 | B2 |
8480730 | Maurer et al. | Jul 2013 | B2 |
8486138 | Vesely | Jul 2013 | B2 |
8506623 | Wilson et al. | Aug 2013 | B2 |
8506624 | Vidlund et al. | Aug 2013 | B2 |
8578705 | Sindano et al. | Nov 2013 | B2 |
8579913 | Nielsen | Nov 2013 | B2 |
8591573 | Barone | Nov 2013 | B2 |
8591576 | Hasenkam et al. | Nov 2013 | B2 |
8597347 | Maurer et al. | Dec 2013 | B2 |
8685086 | Navia et al. | Apr 2014 | B2 |
8790394 | Miller et al. | Jul 2014 | B2 |
8845717 | Khairkhahan et al. | Sep 2014 | B2 |
8888843 | Khairkhahan et al. | Nov 2014 | B2 |
8900214 | Nance et al. | Dec 2014 | B2 |
8900295 | Migliazza et al. | Dec 2014 | B2 |
8926696 | Cabiri et al. | Jan 2015 | B2 |
8932342 | McHugo et al. | Jan 2015 | B2 |
8932348 | Solem et al. | Jan 2015 | B2 |
8945208 | Jimenez et al. | Feb 2015 | B2 |
8956407 | Macoviak et al. | Feb 2015 | B2 |
8979922 | Thambar et al. | Mar 2015 | B2 |
8986376 | Solem | Mar 2015 | B2 |
9011522 | Annest et al. | Apr 2015 | B2 |
9023099 | Duffy et al. | May 2015 | B2 |
9034032 | McLean et al. | May 2015 | B2 |
9034033 | McLean et al. | May 2015 | B2 |
9039757 | McLean et al. | May 2015 | B2 |
9039759 | Alkhatib et al. | May 2015 | B2 |
9078645 | Conklin et al. | Jul 2015 | B2 |
9078749 | Lutter et al. | Jul 2015 | B2 |
9084676 | Chau et al. | Jul 2015 | B2 |
9095433 | Lutter et al. | Aug 2015 | B2 |
9125742 | Yoganathan et al. | Sep 2015 | B2 |
9149357 | Sequin | Oct 2015 | B2 |
9161837 | Kapadia | Oct 2015 | B2 |
9168137 | Subramanian et al. | Oct 2015 | B2 |
9232995 | Kovalsky et al. | Jan 2016 | B2 |
9232998 | Wilson et al. | Jan 2016 | B2 |
9232999 | Maurer et al. | Jan 2016 | B2 |
9241702 | Maisano et al. | Jan 2016 | B2 |
9254192 | Lutter et al. | Feb 2016 | B2 |
9265608 | Miller et al. | Feb 2016 | B2 |
9289295 | Aklog et al. | Mar 2016 | B2 |
9289297 | Wilson et al. | Mar 2016 | B2 |
9345573 | Nyuli et al. | May 2016 | B2 |
9480557 | Pellegrini et al. | Nov 2016 | B2 |
9480559 | Vidlund et al. | Nov 2016 | B2 |
9526611 | Tegels et al. | Dec 2016 | B2 |
9597181 | Christianson et al. | Mar 2017 | B2 |
9610159 | Christianson et al. | Apr 2017 | B2 |
9675454 | Vidlund et al. | Jun 2017 | B2 |
9730792 | Lutter et al. | Aug 2017 | B2 |
9827092 | Vidlund et al. | Nov 2017 | B2 |
9833315 | Vidlund et al. | Dec 2017 | B2 |
9867700 | Bakis et al. | Jan 2018 | B2 |
9883941 | Hastings et al. | Feb 2018 | B2 |
9895221 | Vidlund | Feb 2018 | B2 |
9986993 | Vidlund et al. | Jun 2018 | B2 |
20010018611 | Solem et al. | Aug 2001 | A1 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20010025171 | Mortier et al. | Sep 2001 | A1 |
20020010427 | Scarfone et al. | Jan 2002 | A1 |
20020116054 | Lundell et al. | Aug 2002 | A1 |
20020139056 | Finnell | Oct 2002 | A1 |
20020151961 | Lashinski et al. | Oct 2002 | A1 |
20020161377 | Rabkin | Oct 2002 | A1 |
20020173842 | Buchanan | Nov 2002 | A1 |
20020183827 | Derus et al. | Dec 2002 | A1 |
20030010509 | Hoffman | Jan 2003 | A1 |
20030036698 | Kohler et al. | Feb 2003 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030078652 | Sutherland | Apr 2003 | A1 |
20030100939 | Yodfat et al. | May 2003 | A1 |
20030105519 | Fasol et al. | Jun 2003 | A1 |
20030105520 | Alferness et al. | Jun 2003 | A1 |
20030120340 | Liska et al. | Jun 2003 | A1 |
20030130731 | Vidlund et al. | Jul 2003 | A1 |
20030149476 | Damm et al. | Aug 2003 | A1 |
20030212454 | Scott et al. | Nov 2003 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040049266 | Anduiza et al. | Mar 2004 | A1 |
20040064014 | Melvin et al. | Apr 2004 | A1 |
20040092858 | Wilson et al. | May 2004 | A1 |
20040093075 | Kuehne | May 2004 | A1 |
20040097865 | Anderson et al. | May 2004 | A1 |
20040127983 | Mortier et al. | Jul 2004 | A1 |
20040133263 | Dusbabek et al. | Jul 2004 | A1 |
20040147958 | Lam et al. | Jul 2004 | A1 |
20040152947 | Schroeder et al. | Aug 2004 | A1 |
20040162610 | Liska et al. | Aug 2004 | A1 |
20040163828 | Silverstein et al. | Aug 2004 | A1 |
20040181239 | Dorn et al. | Sep 2004 | A1 |
20040186565 | Schreck | Sep 2004 | A1 |
20040186566 | Hindrichs et al. | Sep 2004 | A1 |
20040260317 | Bloom et al. | Dec 2004 | A1 |
20040260389 | Case et al. | Dec 2004 | A1 |
20050004652 | Van der Burg et al. | Jan 2005 | A1 |
20050004666 | Alfieri et al. | Jan 2005 | A1 |
20050075727 | Wheatley | Apr 2005 | A1 |
20050080402 | Santamore et al. | Apr 2005 | A1 |
20050085900 | Case et al. | Apr 2005 | A1 |
20050096498 | Houser et al. | May 2005 | A1 |
20050107661 | Lau et al. | May 2005 | A1 |
20050113798 | Slater et al. | May 2005 | A1 |
20050113810 | Houser et al. | May 2005 | A1 |
20050113811 | Houser et al. | May 2005 | A1 |
20050119519 | Girard et al. | Jun 2005 | A9 |
20050121206 | Dolan | Jun 2005 | A1 |
20050125012 | Houser et al. | Jun 2005 | A1 |
20050137686 | Salahieh et al. | Jun 2005 | A1 |
20050137688 | Salahieh et al. | Jun 2005 | A1 |
20050137695 | Salahieh et al. | Jun 2005 | A1 |
20050137698 | Salahieh et al. | Jun 2005 | A1 |
20050148815 | Mortier et al. | Jul 2005 | A1 |
20050177180 | Kaganov et al. | Aug 2005 | A1 |
20050197695 | Stacchino | Sep 2005 | A1 |
20050203614 | Forster et al. | Sep 2005 | A1 |
20050203615 | Forster et al. | Sep 2005 | A1 |
20050203617 | Forster et al. | Sep 2005 | A1 |
20050234546 | Nugent et al. | Oct 2005 | A1 |
20050240200 | Bergheim | Oct 2005 | A1 |
20050251209 | Saadat et al. | Nov 2005 | A1 |
20050256567 | Lim et al. | Nov 2005 | A1 |
20050283231 | Haug et al. | Dec 2005 | A1 |
20050288766 | Plain et al. | Dec 2005 | A1 |
20060004442 | Spenser et al. | Jan 2006 | A1 |
20060025784 | Starksen et al. | Feb 2006 | A1 |
20060025857 | Bergheim et al. | Feb 2006 | A1 |
20060030885 | Hyde | Feb 2006 | A1 |
20060042803 | Gallaher | Mar 2006 | A1 |
20060047338 | Jenson et al. | Mar 2006 | A1 |
20060052868 | Mortier et al. | Mar 2006 | A1 |
20060058872 | Salahieh et al. | Mar 2006 | A1 |
20060094983 | Burbank et al. | May 2006 | A1 |
20060129025 | Levine et al. | Jun 2006 | A1 |
20060142784 | Kontos | Jun 2006 | A1 |
20060161040 | McCarthy et al. | Jul 2006 | A1 |
20060161249 | Realyvasquez et al. | Jul 2006 | A1 |
20060167541 | Lattouf | Jul 2006 | A1 |
20060195134 | Crittenden | Aug 2006 | A1 |
20060195183 | Navia et al. | Aug 2006 | A1 |
20060229708 | Powell et al. | Oct 2006 | A1 |
20060229719 | Marquez et al. | Oct 2006 | A1 |
20060241745 | Solem | Oct 2006 | A1 |
20060247491 | Vidlund et al. | Nov 2006 | A1 |
20060252984 | Randert et al. | Nov 2006 | A1 |
20060259135 | Navia et al. | Nov 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060276874 | Wilson et al. | Dec 2006 | A1 |
20060282161 | Huynh et al. | Dec 2006 | A1 |
20060287716 | Banbury et al. | Dec 2006 | A1 |
20060287717 | Rowe et al. | Dec 2006 | A1 |
20070005131 | Taylor | Jan 2007 | A1 |
20070005231 | Seguchi | Jan 2007 | A1 |
20070010877 | Salahieh et al. | Jan 2007 | A1 |
20070016286 | Herrmann et al. | Jan 2007 | A1 |
20070016288 | Gurskis et al. | Jan 2007 | A1 |
20070027535 | Purdy et al. | Feb 2007 | A1 |
20070038291 | Case et al. | Feb 2007 | A1 |
20070050020 | Spence | Mar 2007 | A1 |
20070061010 | Hauser et al. | Mar 2007 | A1 |
20070066863 | Rafiee et al. | Mar 2007 | A1 |
20070073387 | Forster et al. | Mar 2007 | A1 |
20070078297 | Rafiee et al. | Apr 2007 | A1 |
20070083076 | Lichtenstein | Apr 2007 | A1 |
20070083259 | Bloom et al. | Apr 2007 | A1 |
20070093890 | Eliasen et al. | Apr 2007 | A1 |
20070100439 | Cangialosi et al. | May 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070112425 | Schaller et al. | May 2007 | A1 |
20070118151 | Davidson | May 2007 | A1 |
20070118154 | Crabtree | May 2007 | A1 |
20070118210 | Pinchuk | May 2007 | A1 |
20070118213 | Loulmet | May 2007 | A1 |
20070142906 | Figulla et al. | Jun 2007 | A1 |
20070161846 | Nikolic et al. | Jul 2007 | A1 |
20070162048 | Quinn et al. | Jul 2007 | A1 |
20070162103 | Case et al. | Jul 2007 | A1 |
20070168024 | Khairkhahan | Jul 2007 | A1 |
20070185565 | Schwammenthal et al. | Aug 2007 | A1 |
20070185571 | Kapadia et al. | Aug 2007 | A1 |
20070203575 | Forster et al. | Aug 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070215362 | Rodgers | Sep 2007 | A1 |
20070221388 | Johnson | Sep 2007 | A1 |
20070233239 | Navia et al. | Oct 2007 | A1 |
20070239265 | Birdsall | Oct 2007 | A1 |
20070256843 | Pahila | Nov 2007 | A1 |
20070265658 | Nelson et al. | Nov 2007 | A1 |
20070267202 | Mariller | Nov 2007 | A1 |
20070270932 | Headley et al. | Nov 2007 | A1 |
20070270943 | Solem | Nov 2007 | A1 |
20070293944 | Spenser et al. | Dec 2007 | A1 |
20080009940 | Cribier | Jan 2008 | A1 |
20080033543 | Gurskis et al. | Feb 2008 | A1 |
20080065011 | Marchand et al. | Mar 2008 | A1 |
20080071361 | Tuval et al. | Mar 2008 | A1 |
20080071362 | Tuval et al. | Mar 2008 | A1 |
20080071363 | Tuval et al. | Mar 2008 | A1 |
20080071366 | Tuval et al. | Mar 2008 | A1 |
20080071368 | Tuval et al. | Mar 2008 | A1 |
20080071369 | Tuval et al. | Mar 2008 | A1 |
20080082163 | Woo | Apr 2008 | A1 |
20080082166 | Styrc et al. | Apr 2008 | A1 |
20080091264 | Machold et al. | Apr 2008 | A1 |
20080114442 | Mitchell et al. | May 2008 | A1 |
20080125861 | Webler et al. | May 2008 | A1 |
20080147179 | Cai et al. | Jun 2008 | A1 |
20080154355 | Benichou et al. | Jun 2008 | A1 |
20080154356 | Obermiller et al. | Jun 2008 | A1 |
20080161911 | Revuelta et al. | Jul 2008 | A1 |
20080172035 | Starksen et al. | Jul 2008 | A1 |
20080177381 | Navia et al. | Jul 2008 | A1 |
20080183203 | Fitzgerald et al. | Jul 2008 | A1 |
20080183273 | Mesana et al. | Jul 2008 | A1 |
20080188928 | Salahieh et al. | Aug 2008 | A1 |
20080208328 | Antocci et al. | Aug 2008 | A1 |
20080208332 | Lamphere et al. | Aug 2008 | A1 |
20080221672 | Lamphere et al. | Sep 2008 | A1 |
20080243150 | Starksen et al. | Oct 2008 | A1 |
20080243245 | Thambar et al. | Oct 2008 | A1 |
20080255660 | Guyenot et al. | Oct 2008 | A1 |
20080255661 | Straubinger et al. | Oct 2008 | A1 |
20080281411 | Berreklouw | Nov 2008 | A1 |
20080288060 | Kaye et al. | Nov 2008 | A1 |
20080293996 | Evans et al. | Nov 2008 | A1 |
20090005863 | Goetz et al. | Jan 2009 | A1 |
20090048668 | Wilson et al. | Feb 2009 | A1 |
20090054968 | Bonhoeffer et al. | Feb 2009 | A1 |
20090054974 | McGuckin, Jr. et al. | Feb 2009 | A1 |
20090062908 | Bonhoeffer et al. | Mar 2009 | A1 |
20090076598 | Salahieh et al. | Mar 2009 | A1 |
20090082619 | De Marchena | Mar 2009 | A1 |
20090088836 | Bishop et al. | Apr 2009 | A1 |
20090099410 | De Marchena | Apr 2009 | A1 |
20090112309 | Jaramillo | Apr 2009 | A1 |
20090131849 | Maurer et al. | May 2009 | A1 |
20090132035 | Roth et al. | May 2009 | A1 |
20090137861 | Goldberg et al. | May 2009 | A1 |
20090138079 | Tuval et al. | May 2009 | A1 |
20090157175 | Benichou | Jun 2009 | A1 |
20090164005 | Dove et al. | Jun 2009 | A1 |
20090171432 | Von Segesser et al. | Jul 2009 | A1 |
20090171447 | Von Segesser et al. | Jul 2009 | A1 |
20090171456 | Kveen et al. | Jul 2009 | A1 |
20090177266 | Powell et al. | Jul 2009 | A1 |
20090192601 | Rafiee et al. | Jul 2009 | A1 |
20090210052 | Forster et al. | Aug 2009 | A1 |
20090216322 | Le et al. | Aug 2009 | A1 |
20090222076 | Figulla et al. | Sep 2009 | A1 |
20090224529 | Gill | Sep 2009 | A1 |
20090234318 | Loulmet et al. | Sep 2009 | A1 |
20090234435 | Johnson et al. | Sep 2009 | A1 |
20090234443 | Ottma et al. | Sep 2009 | A1 |
20090240320 | Tuval et al. | Sep 2009 | A1 |
20090248149 | Gabbay | Oct 2009 | A1 |
20090276040 | Rowe et al. | Nov 2009 | A1 |
20090281619 | Le et al. | Nov 2009 | A1 |
20090287299 | Tabor et al. | Nov 2009 | A1 |
20090292262 | Adams et al. | Nov 2009 | A1 |
20090319037 | Rowe et al. | Dec 2009 | A1 |
20090326575 | Galdonik et al. | Dec 2009 | A1 |
20100016958 | St. Goar et al. | Jan 2010 | A1 |
20100021382 | Dorshow et al. | Jan 2010 | A1 |
20100023117 | Yoganathan et al. | Jan 2010 | A1 |
20100036479 | Hill et al. | Feb 2010 | A1 |
20100049313 | Alon et al. | Feb 2010 | A1 |
20100082094 | Quadri et al. | Apr 2010 | A1 |
20100161041 | Maisano et al. | Jun 2010 | A1 |
20100168839 | Braido et al. | Jul 2010 | A1 |
20100179641 | Ryan et al. | Jul 2010 | A1 |
20100185277 | Braido et al. | Jul 2010 | A1 |
20100185278 | Schankereli | Jul 2010 | A1 |
20100191326 | Alkhatib | Jul 2010 | A1 |
20100192402 | Yamaguchi et al. | Aug 2010 | A1 |
20100204781 | Alkhatib | Aug 2010 | A1 |
20100210899 | Schankereli | Aug 2010 | A1 |
20100217382 | Chau et al. | Aug 2010 | A1 |
20100249489 | Jarvik | Sep 2010 | A1 |
20100249923 | Alkhatib et al. | Sep 2010 | A1 |
20100280604 | Zipory et al. | Nov 2010 | A1 |
20100286768 | Alkhatib | Nov 2010 | A1 |
20100298755 | McNamara et al. | Nov 2010 | A1 |
20100298931 | Quadri et al. | Nov 2010 | A1 |
20110004296 | Lutter et al. | Jan 2011 | A1 |
20110015616 | Straubinger et al. | Jan 2011 | A1 |
20110015728 | Jimenez et al. | Jan 2011 | A1 |
20110015729 | Jimenez et al. | Jan 2011 | A1 |
20110029072 | Gabbay | Feb 2011 | A1 |
20110066231 | Cartledge et al. | Mar 2011 | A1 |
20110066233 | Thornton et al. | Mar 2011 | A1 |
20110112632 | Chau et al. | May 2011 | A1 |
20110137397 | Chau et al. | Jun 2011 | A1 |
20110137408 | Bergheim | Jun 2011 | A1 |
20110224655 | Asirvatham et al. | Sep 2011 | A1 |
20110224678 | Gabbay | Sep 2011 | A1 |
20110224728 | Martin et al. | Sep 2011 | A1 |
20110224784 | Quinn | Sep 2011 | A1 |
20110245911 | Quill et al. | Oct 2011 | A1 |
20110251682 | Murray, III et al. | Oct 2011 | A1 |
20110264191 | Rothstein | Oct 2011 | A1 |
20110264206 | Tabor | Oct 2011 | A1 |
20110288637 | De Marchena | Nov 2011 | A1 |
20110319988 | Schankereli et al. | Dec 2011 | A1 |
20110319989 | Lane et al. | Dec 2011 | A1 |
20120010694 | Lutter et al. | Jan 2012 | A1 |
20120016468 | Robin et al. | Jan 2012 | A1 |
20120022640 | Gross et al. | Jan 2012 | A1 |
20120035703 | Lutter et al. | Feb 2012 | A1 |
20120035713 | Lutter et al. | Feb 2012 | A1 |
20120035722 | Tuval | Feb 2012 | A1 |
20120053686 | McNamara et al. | Mar 2012 | A1 |
20120059487 | Cunanan et al. | Mar 2012 | A1 |
20120089171 | Hastings et al. | Apr 2012 | A1 |
20120101571 | Thambar et al. | Apr 2012 | A1 |
20120101572 | Kovalsky et al. | Apr 2012 | A1 |
20120116351 | Chomas et al. | May 2012 | A1 |
20120123529 | Levi et al. | May 2012 | A1 |
20120158129 | Duffy et al. | Jun 2012 | A1 |
20120165930 | Gifford et al. | Jun 2012 | A1 |
20120179244 | Schankereli et al. | Jul 2012 | A1 |
20120203336 | Annest | Aug 2012 | A1 |
20120215303 | Quadri et al. | Aug 2012 | A1 |
20120226348 | Lane et al. | Sep 2012 | A1 |
20120283824 | Lutter et al. | Nov 2012 | A1 |
20120289945 | Segermark | Nov 2012 | A1 |
20130030522 | Rowe et al. | Jan 2013 | A1 |
20130053950 | Rowe et al. | Feb 2013 | A1 |
20130066341 | Ketai et al. | Mar 2013 | A1 |
20130079873 | Migliazza et al. | Mar 2013 | A1 |
20130131788 | Quadri et al. | May 2013 | A1 |
20130172978 | Vidlund et al. | Jul 2013 | A1 |
20130184811 | Rowe et al. | Jul 2013 | A1 |
20130190860 | Sundt, III | Jul 2013 | A1 |
20130190861 | Chau et al. | Jul 2013 | A1 |
20130197622 | Mitra et al. | Aug 2013 | A1 |
20130226288 | Goldwasser et al. | Aug 2013 | A1 |
20130231735 | Deem et al. | Sep 2013 | A1 |
20130274874 | Hammer | Oct 2013 | A1 |
20130282101 | Eidenschink et al. | Oct 2013 | A1 |
20130310928 | Morriss et al. | Nov 2013 | A1 |
20130317603 | McLean et al. | Nov 2013 | A1 |
20130325041 | Annest et al. | Dec 2013 | A1 |
20130325110 | Khalil et al. | Dec 2013 | A1 |
20130338752 | Geusen et al. | Dec 2013 | A1 |
20140046433 | Kovalsky | Feb 2014 | A1 |
20140081323 | Hawkins | Mar 2014 | A1 |
20140094918 | Vishnubholta et al. | Apr 2014 | A1 |
20140142691 | Pouletty | May 2014 | A1 |
20140163668 | Rafiee | Jun 2014 | A1 |
20140194981 | Menk et al. | Jul 2014 | A1 |
20140194983 | Kovalsky et al. | Jul 2014 | A1 |
20140214159 | Vidlund et al. | Jul 2014 | A1 |
20140222142 | Kovalsky et al. | Aug 2014 | A1 |
20140243966 | Garde et al. | Aug 2014 | A1 |
20140277419 | Garde et al. | Sep 2014 | A1 |
20140296969 | Tegels et al. | Oct 2014 | A1 |
20140296970 | Ekvall et al. | Oct 2014 | A1 |
20140296971 | Tegels et al. | Oct 2014 | A1 |
20140296972 | Tegels et al. | Oct 2014 | A1 |
20140296975 | Tegels et al. | Oct 2014 | A1 |
20140303718 | Tegels et al. | Oct 2014 | A1 |
20140309732 | Solem | Oct 2014 | A1 |
20140316516 | Vidlund et al. | Oct 2014 | A1 |
20140324160 | Benichou et al. | Oct 2014 | A1 |
20140324161 | Tegels et al. | Oct 2014 | A1 |
20140324164 | Gross et al. | Oct 2014 | A1 |
20140331475 | Duffy et al. | Nov 2014 | A1 |
20140358224 | Tegels et al. | Dec 2014 | A1 |
20140364942 | Straubinger et al. | Dec 2014 | A1 |
20140364944 | Lutter et al. | Dec 2014 | A1 |
20140379076 | Vidlund et al. | Dec 2014 | A1 |
20150005874 | Vidlund et al. | Jan 2015 | A1 |
20150011821 | Gorman et al. | Jan 2015 | A1 |
20150025553 | Del Nido et al. | Jan 2015 | A1 |
20150057705 | Vidlund et al. | Feb 2015 | A1 |
20150073542 | Heldman | Mar 2015 | A1 |
20150073545 | Braido | Mar 2015 | A1 |
20150094802 | Buchbinder et al. | Apr 2015 | A1 |
20150105856 | Rowe et al. | Apr 2015 | A1 |
20150119936 | Gilmore et al. | Apr 2015 | A1 |
20150119978 | Tegels et al. | Apr 2015 | A1 |
20150127093 | Hosmer et al. | May 2015 | A1 |
20150127096 | Rowe et al. | May 2015 | A1 |
20150134050 | Solem et al. | May 2015 | A1 |
20150142100 | Morriss et al. | May 2015 | A1 |
20150142101 | Coleman et al. | May 2015 | A1 |
20150142103 | Vidlund | May 2015 | A1 |
20150142104 | Braido | May 2015 | A1 |
20150173897 | Raanani et al. | Jun 2015 | A1 |
20150196393 | Vidlund et al. | Jul 2015 | A1 |
20150196688 | James et al. | Jul 2015 | A1 |
20150202044 | Chau et al. | Jul 2015 | A1 |
20150216653 | Freudenthanl | Aug 2015 | A1 |
20150216660 | Pintor et al. | Aug 2015 | A1 |
20150223820 | Olson et al. | Aug 2015 | A1 |
20150223934 | Vidlund et al. | Aug 2015 | A1 |
20150238312 | Lashinski | Aug 2015 | A1 |
20150238729 | Jenson et al. | Aug 2015 | A1 |
20150272731 | Racchini et al. | Oct 2015 | A1 |
20150305860 | Wang et al. | Oct 2015 | A1 |
20150305864 | Quadri et al. | Oct 2015 | A1 |
20150305868 | Lutter et al. | Oct 2015 | A1 |
20150327995 | Morin et al. | Nov 2015 | A1 |
20150328001 | McLean et al. | Nov 2015 | A1 |
20150335424 | McLean et al. | Nov 2015 | A1 |
20150335429 | Morriss et al. | Nov 2015 | A1 |
20150342717 | O'Donnell et al. | Dec 2015 | A1 |
20150351903 | Morriss et al. | Dec 2015 | A1 |
20150351906 | Hammer et al. | Dec 2015 | A1 |
20160000562 | Siegel | Jan 2016 | A1 |
20160008131 | Christianson et al. | Jan 2016 | A1 |
20160067042 | Murad et al. | Mar 2016 | A1 |
20160074160 | Christianson et al. | Mar 2016 | A1 |
20160106537 | Christianson et al. | Apr 2016 | A1 |
20160113764 | Sheahan et al. | Apr 2016 | A1 |
20160143736 | Vidlund et al. | May 2016 | A1 |
20160151155 | Lutter et al. | Jun 2016 | A1 |
20160206280 | Vidlund et al. | Jul 2016 | A1 |
20160242902 | Morriss et al. | Aug 2016 | A1 |
20160262879 | Meiri et al. | Sep 2016 | A1 |
20160262881 | Schankereli et al. | Sep 2016 | A1 |
20160278955 | Liu et al. | Sep 2016 | A1 |
20160317290 | Chau et al. | Nov 2016 | A1 |
20160324635 | Vidlund et al. | Nov 2016 | A1 |
20160346086 | Solem | Dec 2016 | A1 |
20160367365 | Conklin | Dec 2016 | A1 |
20160367367 | Maisano et al. | Dec 2016 | A1 |
20160367368 | Vidlund et al. | Dec 2016 | A1 |
20170079790 | Vidlund et al. | Mar 2017 | A1 |
20170100248 | Tegels et al. | Apr 2017 | A1 |
20170128208 | Christianson et al. | May 2017 | A1 |
20170181854 | Christianson et al. | Jun 2017 | A1 |
20170252153 | Chau et al. | Sep 2017 | A1 |
20170266001 | Vidlund et al. | Sep 2017 | A1 |
20170281343 | Christianson et al. | Oct 2017 | A1 |
20170312076 | Lutter et al. | Nov 2017 | A1 |
20170312077 | Vidlund et al. | Nov 2017 | A1 |
20170319333 | Tegels et al. | Nov 2017 | A1 |
20180028314 | Ekvall et al. | Feb 2018 | A1 |
20180078368 | Vidlund et al. | Mar 2018 | A1 |
20180078370 | Kovalsky et al. | Mar 2018 | A1 |
20180147055 | Vidlund et al. | May 2018 | A1 |
20180193138 | Vidlund | Jul 2018 | A1 |
20180263618 | Vidlund et al. | Sep 2018 | A1 |
Number | Date | Country |
---|---|---|
1486161 | Mar 2004 | CN |
1961845 | May 2007 | CN |
2902226 | May 2007 | CN |
101146484 | Mar 2008 | CN |
101180010 | May 2008 | CN |
101984938 | Mar 2011 | CN |
102869317 | Jan 2013 | CN |
102869318 | Jan 2013 | CN |
102869321 | Jan 2013 | CN |
103220993 | Jul 2013 | CN |
102639179 | Oct 2014 | CN |
2246526 | Mar 1973 | DE |
19532846 | Mar 1997 | DE |
19546692 | Jun 1997 | DE |
19857887 | Jul 2000 | DE |
19907646 | Aug 2000 | DE |
10049812 | Apr 2002 | DE |
10049813 | Apr 2002 | DE |
10049815 | Apr 2002 | DE |
102006052564 | Dec 2007 | DE |
102006052710 | May 2008 | DE |
102007043830 | Apr 2009 | DE |
102007043831 | Apr 2009 | DE |
0103546 | May 1988 | EP |
1057460 | Dec 2000 | EP |
1088529 | Apr 2001 | EP |
1469797 | Nov 2005 | EP |
2111800 | Oct 2009 | EP |
2193762 | Jun 2010 | EP |
2747707 | Apr 2015 | EP |
2918248 | Sep 2015 | EP |
2278944 | Mar 2016 | EP |
2788217 | Jul 2000 | FR |
2815844 | May 2002 | FR |
2003-505146 | Feb 2003 | JP |
2005-515836 | Jun 2005 | JP |
2009-514628 | Apr 2009 | JP |
2009-519783 | May 2009 | JP |
2013-512765 | Apr 2013 | JP |
1017275 | Aug 2002 | NL |
1271508 | Nov 1986 | SU |
WO 9217118 | Oct 1992 | WO |
WO 9301768 | Feb 1993 | WO |
WO 9829057 | Jul 1998 | WO |
WO 9940964 | Aug 1999 | WO |
WO 9947075 | Sep 1999 | WO |
WO 2000018333 | Apr 2000 | WO |
WO 2000030550 | Jun 2000 | WO |
WO 2000041652 | Jul 2000 | WO |
WO 2000047139 | Aug 2000 | WO |
WO 2001035878 | May 2001 | WO |
WO 2001049213 | Jul 2001 | WO |
WO 2001054624 | Aug 2001 | WO |
WO 2001054625 | Aug 2001 | WO |
WO 2001056512 | Aug 2001 | WO |
WO 2001061289 | Aug 2001 | WO |
WO 2001076510 | Oct 2001 | WO |
WO 2001082840 | Nov 2001 | WO |
WO 2002004757 | Jan 2002 | WO |
WO 2002022054 | Mar 2002 | WO |
WO 2002028321 | Apr 2002 | WO |
WO 2002036048 | May 2002 | WO |
WO 2002041789 | May 2002 | WO |
WO 2002043620 | Jun 2002 | WO |
WO 2002049540 | Jun 2002 | WO |
WO 2002076348 | Oct 2002 | WO |
WO 2003003943 | Jan 2003 | WO |
WO 2003030776 | Apr 2003 | WO |
WO 2003047468 | Jun 2003 | WO |
WO 2003049619 | Jun 2003 | WO |
WO 2004019825 | Mar 2004 | WO |
WO 2005102181 | Nov 2005 | WO |
WO 2006014233 | Feb 2006 | WO |
WO 2006034008 | Mar 2006 | WO |
WO 2006064490 | Jun 2006 | WO |
WO 2006070372 | Jul 2006 | WO |
WO 2006105009 | Oct 2006 | WO |
WO 2006113906 | Oct 2006 | WO |
WO 2006127756 | Nov 2006 | WO |
WO 2007081412 | Jul 2007 | WO |
WO 2007100408 | Sep 2007 | WO |
WO 2008005405 | Jan 2008 | WO |
WO 2008035337 | Mar 2008 | WO |
WO 2008091515 | Jul 2008 | WO |
WO 2008125906 | Oct 2008 | WO |
WO 2008147964 | Dec 2008 | WO |
WO 2009024859 | Feb 2009 | WO |
WO 2009026563 | Feb 2009 | WO |
WO 2009045338 | Apr 2009 | WO |
WO 2009132187 | Oct 2009 | WO |
WO 2010090878 | Aug 2010 | WO |
WO 2010098857 | Sep 2010 | WO |
WO 2010121076 | Oct 2010 | WO |
WO 2011017440 | Feb 2011 | WO |
WO 2011022658 | Feb 2011 | WO |
WO 2011069048 | Jun 2011 | WO |
WO 2011072084 | Jun 2011 | WO |
WO 2011106735 | Sep 2011 | WO |
WO 2011109813 | Sep 2011 | WO |
WO 2011159342 | Dec 2011 | WO |
WO 2011163275 | Dec 2011 | WO |
WO 2012027487 | Mar 2012 | WO |
WO 2012036742 | Mar 2012 | WO |
WO 2012095116 | Jul 2012 | WO |
WO 2012177942 | Dec 2012 | WO |
WO 2013028387 | Feb 2013 | WO |
WO 2013045262 | Apr 2013 | WO |
WO 2013059747 | Apr 2013 | WO |
WO 2013096411 | Jun 2013 | WO |
WO 2013175468 | Nov 2013 | WO |
WO 2014121280 | Aug 2014 | WO |
WO 2014144937 | Sep 2014 | WO |
WO 2014162306 | Oct 2014 | WO |
WO 2014189974 | Nov 2014 | WO |
WO 2015051430 | Apr 2015 | WO |
WO 2015058039 | Apr 2015 | WO |
WO 2015063580 | May 2015 | WO |
WO 2015065646 | May 2015 | WO |
WO 2015120122 | Aug 2015 | WO |
WO 2015138306 | Sep 2015 | WO |
WO 2015173609 | Nov 2015 | WO |
WO 2016112085 | Jul 2016 | WO |
WO 2016126942 | Aug 2016 | WO |
WO 2016168609 | Oct 2016 | WO |
WO 2016196933 | Dec 2016 | WO |
WO 2017096157 | Jun 2017 | WO |
WO 2017132008 | Aug 2017 | WO |
WO 2017218375 | Dec 2017 | WO |
WO 2018005779 | Jan 2018 | WO |
WO 2018013515 | Jan 2018 | WO |
Entry |
---|
US 9,155,620 B2, 10/2015, Gross et al. (withdrawn) |
First Office Action for Chinese Application No. 201480037269.5, dated Dec. 23, 2016, 10 pages. |
Examination Report for European Application No. 14734333.9, dated Oct. 20, 2016, 6 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2014/040188, dated Nov. 17, 2014, 12 pages. |
Invitation to Pay Additional Fees and Partial International Search Report for International Application No. PCT/US2014/040188, dated Sep. 8, 2014, 5 pages. |
Office Action for U.S. Appl. No. 14/950,656, dated Apr. 22, 2016, 5 pages. |
Al Zaibag, M. et al., “Percutaneous Balloon Valvotomy in Tricuspid Stenosis,” British Heart Journal, Jan. 1987, 57(1):51-53. |
Al-Khaja, N. et al., “Eleven Years' Experience with Carpentier-Edwards Biological Valves in Relation to Survival and Complications,” European Journal of Cardiothoracic Surgery, Jun. 30, 1989, 3:305-311. |
Almagor, Y. et al., “Balloon Expandable Stent Implantation in Stenotic Right Heart Valved Conduits,” Journal of the American College of Cardiology, Nov. 1, 1990, 16(6):1310-1314. |
Andersen, H. R. et al., “Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs,” European Heart Journal, 1992, 13(5):704-708. |
Andersen, H. R., “History of Percutaneous Aortic Valve Prosthesis,” Herz, Aug. 2009, 34(5):343-346. |
Andersen, H. R., “Transluminal catheter implanted prosthetic heart valves,” International Journal of Angiology, 1998, 7(2):102-106. |
Ashton, R. C., Jr. et al., “Development of an Intraluminal Device for the Treatment of Aortic Regurgitation: Prototype and in Vitro Testing System,” Journal of Thoracic and Cardiovascular Surgery, 1996, 112:979-983. |
Benchimol, A. et al., “Simultaneous Left Ventricular Echocardiography and Aortic Blood Velocity During Rapid Right Ventricular Pacing in Man,” The American Journal of the Medical Sciences, Jan.-Feb. 1977, 273(1):55-62. |
Bernacca, G. M. et al., “Polyurethane heart valves: Fatigue failure, calcification, and polyurethane structure,” Journal of Biomedical Materials Research, Mar. 5, 1997, 34(3):371-379. |
Boudjemline, Y. et al., “Steps Toward the Percutaneous Replacement of Atrioventricular Valves: An Experimental Study,” Journal of the American College of Cardiology, Jul. 2005, 46(2):360-365. |
Buckberg, G. et al., “Restoring Papillary Muscle Dimensions During Restoration in Dilated Hearts,” Interactive CardioVascular and Thoracic Surgery, 2005, 4:475-477. |
Chamberlain, G., “Ceramics Replace Body Parts,” Design News, Jun. 9, 1997, Issue 11, vol. 52, 5 pages. |
Choo, S. J. et al., “Aortic Root Geometry: Pattern of Differences Between Leaflets and Sinuses of Valsava,” The Journal of Heart Valve Disease, Jul. 1999, 8:407-415. |
Declaration of Malcolm J. R. Dalrymple-Hay, Nov. 9, 2012, pp. 1-11; with Curriculum Vitae, Oct. 4, 2012. |
Dotter, C. T. et al., “Transluminal Treatment of Arteriosclerotic Obstruction. Description of a New Technic and a Preliminary Report of its Application,” Circulation, Nov. 1964, 30:654-670. |
Drawbaugh, K., “Feature—Heart Surgeons Explore Minimally Invasive Methods,” Reuters Limited, Jul. 16, 1996, 3 pages. |
Gray, H., The Aorta, Anatomy of the Human Body, 1918, Retrieved from the Internet <http://www.bartleby.com/107/142.html> , Dec. 10, 2012, 5 pages. |
Gray, H., The Heart, Anatomy of the Human Body, 1918, Retrieved from the Internet <http://education.yahoo.com/reference/gray/subjects/subject/138> , Aug. 10, 2012, 9 pages. |
Greenhalgh, E. S., “Design and characterization of a biomimetic prosthetic aortic heart valve,” 1994, ProQuest Dissertations and Theses, Department of Fiber and Polymer Science, North Carolina State University at Raleigh, 159 pages. |
Inoue, K. et al., “Clinical Application of Transvenous Mitral Commissurotomy by a New Balloon Catheter,” The Journal of Thoracic and Cardiovascular Surgery, 1984, 87:394-402. |
Jin, X. Y. et al., “Aortic Root Geometry and Stentless Porcine Valve Competence,” Seminars in Thoracic and Cardiovascular Surgery, Oct. 1999, 11(4):145-150. |
Knudsen, L. L. et al., “Catheter-implanted prosthetic heart valves. Transluminal catheter implantation of a new expandable artificial heart valve in the descending thoracic aorta in isolated vessels and closed chest pigs,” The International Journal of Artificial Organs, 1993, 16(5):253-262. |
Kolata, G., “Device That Opens Clogged Arteries Gets a Failing Grade in a New Study,” New York Times [online], <http://www.nytimes.com/1991/01/03/health/device-that-opens-clogged-arteries-gets-a-faili . . . ,>, published Jan. 3, 1991, retrieved from the Internet on Feb. 5, 2016, 3 pages. |
Lawrence, D. D., “Percutaneous Endovascular Graft: Experimental Evaluation,” Radiology, 1987, 163:357-360. |
Lozonschi, L., et al. “Transapical mitral valved stent implantation: A survival series in swine,” The Journal of Thoracic and Cardiovascular Surgery, 140(2):422-426 (Aug. 2010) published online Mar. 12, 2010, 1 page. |
Lutter, G. et al., “Mitral Valved Stent Implantation,” European Journal of Cardio-Thoracic Surgery, 2010, 38:350-355, 2 pages. |
Ma, L. et al., “Double-crowned valved stents for off-pump mitral valve replacement,” European Journal of Cardio-Thoracic Surgery, Aug. 2005, 28(2):194-198. |
Moazami, N. et al., “Transluminal aortic valve placement: A feasibility study with a newly designed collapsible aortic valve,” ASAIO Journal, Sep./ Oct. 1996, 42(5):M381-M385. |
Orton, C., “Mitralseal: Hybrid Transcatheter Mitral Valve Replacement,” Retrieved from the Internet: <http:/www.acvs.org/symposium/proceedings2011/data/papers/102.pdf>, pp. 311-312. |
Pavcnik, D. et al. “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Radiology, 1992; 183:151-154. |
Porstmann, W. et al., “Der Verschluß des Ductus Arteriosus Persistens ohne Thorakotomie,” Thoraxchirurgie Vaskulare Chirurgie, Band 15, Heft 2, Stuttgart, Apr. 1967, pp. 199-203. |
Rashkind, W. J., “Creation of an Atrial Septal Defect Without Thoracotomy,” The Journal of the American Medical Association, Jun. 13, 1966, 196(11):173-174. |
Rashkind, W. J., “Historical Aspects of Interventional Cardiology: Past, Present, Future,” Texas Heart Institute Journal, Dec. 1986, 13(4):363-367. |
Reul, H. et al., “The Geometry of the Aortic Root in Health, at Valve Disease and After Valve Replacement,” J. Biomechanics, 1990, 23(2):181-191. |
Rosch, J. et al., “The Birth, Early Years and Future of Interventional Radiology,” J Vasc Interv Radiol., Jul. 2003, 4:841-853. |
Ross, D. N., “Aortic Valve Surgery,” Guy's Hospital, London, 1968, pp. 192-197. |
Rousseau, E. P. M. et al., “A mechanical analysis of the closed Hancock heart valve prosthesis,” Journal of Biomechanics, 1988, 21(7):545-562. |
Sabbah, A. N. et al., “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview,” Dec. 1989, Journal of Cardiac Surgery, 4(4):302-309. |
Selby, J. B., “Experience with New Retrieval Forceps for Foreign Body Removal in the Vascular, Urinary, and Biliary Systems,” Radiology, 1990, 176:535-538. |
Serruys, P. W. et al., “Stenting of Coronary Arteries. Are we the Sorcerer's Apprentice?,” European Heart Journal , Sep. 1989, 10(9):774-782. |
“Shape Memory Alloys,” Retrieved from the Internet: <http://webdocs.cs.ualberta.ca/˜database/MEMS/sma.html>, Feb. 5, 2016, 3 pages. |
Sigwart, U., “An Overview of Intravascular Stents: Old and New,” Chapter 48, Interventional Cardiology, 2nd Edition, W.B. Saunders Company, Philadelphia, PA, © 1994, 1990, pp. 803-815. |
Tofeig, M. et al., “Transcatheter Closure of a Mid-Muscular Ventricular Septal Defect with an Amplatzer VSD Occluder Device,” Heart, 1999, 81:438-440. |
Uchida, B. T. et al., “Modifications of Gianturco Expandable Wire Stents,” Am. J. Roentgenol., May 1988, 150(5):1185-1187. |
Watt, A. H. et al., “Intravenous Adenosine in the Treatment of the Supraventricular Tachycardia; a Dose-Ranging Study and Interaction with Dipyridamole,” British Journal of Clinical Pharmacology, 1986, 21:227-230. |
Webb, J. G. et al., “Percutaneous Aortic Valve Implantation Retrograde from the Femoral Artery,” Circulation, 2006, 113:842-850. |
Wheatley, D. J., “Valve Prostheses,” Rob & Smith's Operative Surgery, Fourth Edition, 1986, pp. 415-424, Butterworths. |
Yoganathan, A. P. et al., “The Current Status of Prosthetic Heart Valves,” In Polymetric Materials and Artificial Organs, American Chemical Society, 1984, pp. 111-150. |
Examination Report No. 1 for Australian Application No. 2014274056, dated Mar. 6, 2018, 4 pages. |
Examination Report No. 2 for Australian Application No. 2014274056, dated May 9, 2018, 2 pages. |
Second Office Action for Chinese Application No. 201480037269.5, dated Nov. 6, 2017, 6 pages. |
Third Office Action for Chinese Application No. 201480037269.5, dated Jun. 19, 2018, 8 pages. |
Notice of Reasons for Rejection for Japanese Application No. 2016-517032, dated Feb. 13, 2018, 5 pages. |
Extended European Search Report for European Application No. 18160595.7, dated Sep. 14, 2018, 7 pages. |
Number | Date | Country | |
---|---|---|---|
20170196688 A1 | Jul 2017 | US |
Number | Date | Country | |
---|---|---|---|
61829076 | May 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14950656 | Nov 2015 | US |
Child | 15472935 | US | |
Parent | PCT/US2014/040188 | May 2014 | US |
Child | 14950656 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14155417 | Jan 2014 | US |
Child | PCT/US2014/040188 | US |